Grifols SA (GRFS)
8.535
-0.06
(-0.76%)
USD |
NASDAQ |
Nov 21, 16:00
8.535
0.00 (0.00%)
After-Hours: 20:00
Grifols Price: 8.535 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 8.45 | 8.605 | 8.37 | 8.60 | 625230.0 |
| Nov 19, 2024 | 8.28 | 8.58 | 8.27 | 8.46 | 952771.0 |
| Nov 18, 2024 | 9.22 | 9.44 | 9.15 | 9.22 | 1.781M |
| Nov 15, 2024 | 9.68 | 9.69 | 9.43 | 9.47 | 1.192M |
| Nov 14, 2024 | 9.52 | 9.75 | 9.42 | 9.55 | 2.008M |
| Nov 13, 2024 | 9.16 | 9.275 | 9.04 | 9.09 | 2.515M |
| Nov 12, 2024 | 9.27 | 9.27 | 9.040 | 9.10 | 442288.0 |
| Nov 11, 2024 | 9.45 | 9.51 | 9.07 | 9.32 | 669454.0 |
| Nov 08, 2024 | 9.96 | 9.96 | 9.46 | 9.49 | 1.408M |
| Nov 07, 2024 | 9.26 | 9.94 | 9.12 | 9.50 | 2.063M |
| Nov 06, 2024 | 9.04 | 9.12 | 8.86 | 9.05 | 807440.0 |
| Nov 05, 2024 | 8.74 | 9.38 | 8.694 | 9.29 | 1.336M |
| Nov 04, 2024 | 8.92 | 8.96 | 8.775 | 8.80 | 472749.0 |
| Nov 01, 2024 | 8.74 | 8.855 | 8.74 | 8.84 | 715154.0 |
| Oct 31, 2024 | 8.62 | 8.755 | 8.51 | 8.69 | 1.370M |
| Oct 30, 2024 | 8.44 | 8.795 | 8.38 | 8.77 | 1.268M |
| Oct 29, 2024 | 8.73 | 8.73 | 8.11 | 8.20 | 1.585M |
| Oct 28, 2024 | 8.39 | 8.56 | 8.30 | 8.34 | 602408.0 |
| Oct 25, 2024 | 8.80 | 8.85 | 8.725 | 8.73 | 504574.0 |
| Oct 24, 2024 | 8.77 | 8.87 | 8.61 | 8.86 | 581868.0 |
| Oct 23, 2024 | 8.80 | 8.90 | 8.63 | 8.83 | 426596.0 |
| Oct 22, 2024 | 8.71 | 8.83 | 8.65 | 8.82 | 544023.0 |
| Oct 21, 2024 | 8.70 | 8.74 | 8.51 | 8.57 | 280141.0 |
| Oct 18, 2024 | 8.54 | 8.67 | 8.44 | 8.65 | 410319.0 |
| Oct 17, 2024 | 8.44 | 8.64 | 8.42 | 8.59 | 312767.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
5.47
Minimum
Mar 06 2024
25.63
Maximum
Feb 21 2020
12.71
Average
10.99
Median
Price Benchmarks
| DBV Technologies SA | 0.485 |
| Cellectis SA | 1.88 |
| Akari Therapeutics PLC | 1.28 |
| Biodexa Pharmaceuticals PLC | 4.36 |
| NuCana PLC | 1.27 |
Price Related Metrics
| PE Ratio | 26.89 |
| PS Ratio | 0.7831 |
| PEG Ratio | 5.901 |
| Price to Book Value | 0.9708 |
| Earnings Yield | 3.72% |
| Market Cap | 5.801B |
| PEGY Ratio | 5.901 |
| Operating PE Ratio | 5.099 |
| Normalized PE Ratio | 24.54 |